Missouri Pharmacy Association

12/05/2025

The PBMs and insurance conglomerates are driving up drug costs, crushing small-business pharmacies, and creating pharmacy deserts. There is wide bipartisan support for these reforms, so there are no excuses for letting another year slip by without passing them.

WASHINGTON – U.S. Senate Finance Committee Chairman Mike Crapo, R-Idaho, and Ranking Member Ron Wyden, D-Ore., today introduced the Pharmacy Benefit Manager (PBM) Price Transparency and Accountability

12/05/2025

Yesterday, Senate Finance Committee Chairman Mike Crapo (R-Idaho) and Ranking Member Senator Ron Wyden (D-Ore.) introduced the PBM Price Transparency and Accountability Act, a bill that would finally require accountability of pharmacy benefit managers that are systematically raising drug prices for patients and causing pharmacy deserts to expand.

Read more here:

Yesterday, Senate Finance Committee Chairman Mike Crapo (R-Idaho) and Ranking Member Senator Ron Wyden (D-Ore.) introduced the PBM Price Transparency and Accountability Act, a bill that would finally require accountability of pharmacy benefit managers that are systematically raising drug prices for....

12/04/2025

Simply put, the current dynamic is unsustainable.

With PBMs serving as middlemen, prescription drug prices continue to rise with no relief in sight. PBMs are content to watch their profit margins increase while patients, small businesses, and independent pharmacies struggle.

Something has got to give.

Rising inflation and increasing costs have left the average American feeling the financial pinch. Everywhere you turn these days, the […]

12/04/2025

Implementation of Medicare Drug Price Negotiation Program Provisions

CMS will host a call for pharmacies, pharmacists, and pharmacy-related groups on the Medicare Drug Price Negotiation Program on Tuesday, December 16, 2025, at 3:00 PM ET. This virtual office hour will focus on the MTF enrollment process.

REGISTER: https://www.zoomgov.com/webinar/register/WN_wZP91ZqKRoaSoQMneS2grg #/registration

Submit questions by December 12 to IRARebateandNegotiation@cms.hhs.gov (subject: “12/16 Discussion Question – Pharmacy”).

Register by December 12. Approval is required; approved participants will receive the Zoom link and agenda. The call is limited to pharmacy-related attendees.

For help, email IRARebateandNegotiation@cms.hhs.gov

12/03/2025

Congressman Jason Smith…expressing his wholehearted backing of Missouri’s application for Rural Health Transformation Program funding. The historic, 50-billion-buck investment in rural health…was …

12/03/2025

Missouri Pharmacy Association Recognized in Missouri’s Rural Health Transformation Plan!

We’re proud to share that Missouri Pharmacy Association is specifically recognized in Missouri’s Rural Health Transformation (RHT) Plan, endorsed by Governor Mike Kehoe. This acknowledgment reflects the vital role pharmacy plays in strengthening access to care and improving health outcomes for .

This achievement builds on the momentum created by the Pharmacy Vaccine Gap Closure Program—launched in 2024 by MPA, CPESN® Missouri, and CPESN Community Health. This groundbreaking initiative transformed education and distribution in , proving the power of -led solutions. The results were clear: pharmacies bridge care gaps and drive meaningful public health outcomes.

Now, through the Rural Health Transformation Plan, Missouri is taking the next step—expanding data pipelines, improving care coordination, and further elevating the role of pharmacy in rural healthcare.

Missouri pharmacy is not just participating. We are transforming.

Stay tuned—this is only the beginning, and we can’t wait to share what’s next.

12/03/2025

I’m Penni Cillin! Here to dose out fun, mischief, and be a bit of a pill for MPA's team at the office this holiday season. Let the shenanigans begin!

12/03/2025

Action Required: Enroll in the Medicare Transaction Facilitator (MTF)

If your pharmacy plans to participate in any Medicare Part D network next year, you must enroll in the MTF Data Module (MTF-DM) to receive manufacturer refund payments. Before enrolling, ensure your NCPDP profile is accurate, decide which functions (e.g., central pay or reconciliation) to assign to third-party support entities, and be ready to sign a legal agreement (review with counsel). Indicate any material cashflow concerns to receive mitigation plans from manufacturers. Enrollment takes about 1 hour and requires banking information.

Watch an intro: https://www.cms.gov/priorities/medicare-prescription-drug-affordability/overview/medicare-drug-price-negotiation-program/pharmacy-dispensing-entity-resources

Review CMS’ FAQ:https://www.cms.gov/files/document/pharmacy-and-dispensing-entity-mtf-faq.pdf

We STRONGLY encourage enrollment before Jan. 1, 2026, though enrollment will remain ongoing.

Questions? MFPMedicareTransactionFacilitator@cms.hhs.gov

12/03/2025

Today we wrapped gifts for our MPA Christmas family!

12/02/2025

Do you do 340B? Must watch webinar!

The Inflation Reduction Act is reshaping the landscape of drug pricing and reimbursement, and the 340B program is squarely in the eye of the storm.

Thursday, Dec. 11 at 2 p.m. ET, for
"340B-rrr: Feeling the Chill of the IRA,"

A timely webinar that unpacks how Medicare price negotiations and manufacturer rebates are reverberating across covered entities and contract pharmacies. Industry experts will provide the latest updates, while a representative from a covered entity will bring real-world insights from the front lines. Don’t miss this opportunity to stay ahead of the curve and gain practical knowledge to navigate the evolving 340B environment.

Register here: https://us06web.zoom.us/webinar/register/WN_0mRl1DQJQLSSlmLSYdWL1w #/registration

National Community Pharmacists Association

As the Inflation Reduction Act continues to reshape drug pricing and reimbursement, the 340B program finds itself in the middle of a policy snowstorm. This timely session explores how the IRA’s provisions—especially around Medicare price negotiations and manufacturer rebates—are impacting cove...

12/02/2025

Your December Monthly Med Safety Tip from Alliance for Patient Medication Safety!

12/01/2025

WAC PRICE DROPS ARE HERE — ACT NOW!

Major WAC decreases are hitting popular drugs — some of the biggest cuts in industry history (estimated up to $50 billion). Drugs like Eliquis, Jardiance, and Farxiga are on the list.

If you keep higher-WAC inventory on your shelves, PBMs will reimburse you at the new lower WAC — meaning you could lose tens of thousands of dollars. Some wholesalers are already blocking returns, leaving pharmacies stuck with higher-cost stock.

What to do RIGHT NOW:
• Review your inventory
• Cross-check items with WAC decreases
• Clear out will-call for affected meds
• Watch for wholesaler WAC announcements
• Understand return-block policies
• Streamline inventory + use on-demand ordering
• Enroll in CMS’ Medicare Transaction Facilitator program to secure manufacturer refunds on the first 10 negotiated drugs

Don’t wait — protect your pharmacy from massive losses.